Calcimedica set to join russell microcap® index

La jolla, calif., july 1, 2024 /prnewswire/ -- calcimedica inc. ("calcimedica" or the "company") (nasdaq: calc), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium ("crac") channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the company is set to join the russell microcap ®  index at the conclusion of the 2024 russell u.s. indexes annual reconstitution, effective at the open of u.s. equity markets on monday, july 1, 2024, according to preliminary lists of additions posted on friday, may 24, 2024.
CALC Ratings Summary
CALC Quant Ranking